期刊文献+

清热安血汤治疗原发性血小板减少性紫癜34例总结 被引量:2

原文传递
导出
摘要 目的:观察清热安血汤治疗原发性血小板减少性紫癜(ITP)血热妄行证的临床疗效。方法:将68例ITP血热妄行证患者随机分为治疗组和对照组,每组各34例。治疗组采用醋酸泼尼松片联合清热安血汤治疗,对照组单用醋酸泼尼松片治疗,观察比较2组治疗前后血小板计数及出血情况,评定综合疗效。结果:总有效率治疗组为88. 24%,对照组为76. 47%,组间比较,差异有统计学意义(P <0. 05);2组血小板计数治疗前后组内比较及治疗后组间比较,差异均有统计学意义(P <0. 05)。结论:清热安血汤治疗ITP血热妄行证可升高血小板计数,缓解症状,临床疗效明显。
出处 《湖南中医杂志》 2019年第6期51-52,共2页 Hunan Journal of Traditional Chinese Medicine
  • 相关文献

参考文献1

二级参考文献32

  • 1Rodeghiero F,Stasi R,Gernsheimer T,et al.Standardization of terminology,definitions and outcome criteria in immune thrombocytopenic purpura of adults and children:report from an international working group[J].Blood,2009,113:2386-2393.
  • 2Provan D,Stasi R,Newland AC,et al.International consensus report on the investigation and management of primary immune thrombocytopenia[J].Blood,2010,115:168-186.
  • 3Neunert C,Lim W,Crowther M,et al.The American Society of Hematology 2011evidence-based practice guideline for immune thrombocytopenia[J].Blood,2011,117:4190-4207.
  • 4Liu XG,Li JL,Qin P,et al.Determination of plateletbound glycoprotein-specific autoantibodies by flow cytometric immunobead assay in primary immune thrombocytopenia[J].Eur J Haematol,2011,86:339-346.
  • 5Wei Y,Ji XB,Wang YW,et al.High-dose dexamethasone versus prednisone for treatment of adult immune thrombocytopenia:aprospective multicenter randomized trial[J].Blood,2016,127:296-302.
  • 6Wang S,Yang R,Zou P,et al.A multicenter randomized controlled trial of recombinant human thrombopoietin treatment in patients with primary immune thrombocytopenia[J].Int J Hematol,2012,96:222-228.
  • 7Bussel JB,Cheng G,Saleh MN,et al.Eltrombopag for the treatment of chronic idiopathic thrombocytopenic purpura[J].N Engl J Med,2007,357:2237-2247.
  • 8Bussel JB,Provan D,Shamsi T,et al.Effect of eltrombopag on platelet counts and bleeding during treatment of chronic idiopathic thrombocytopenic purpura:a randomised,double-blind,placebo-controlled trial[J].Lancet,2009,373:641-648.
  • 9Cheng G,Saleh MN,Marcher C,et al.Eltrombopag for management of chronic immune thrombocytopenia(RAISE):a 6-month,randomised,phase 3study[J].Lancet,2011,377:393-402.
  • 10Saleh MN,Bussel JB,Cheng G,et al.Safety and efficacy of eltrombopag for treatment of chronic immune thrombocytopenia:results of the long-term,open-label EXTEND study[J].Blood,2013,121:537-545.

共引文献87

同被引文献35

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部